Market Size (2016)
2016
$5.67B
Vertical: HealthcareBase Year: 201811 Sections
Market Size (2016)
2016
$5.67B
Projected (2025)
2025
$8.56B
CAGR (2016–2025)
4.7%
4.7%Key Players
107+
Nephrectomy is a surgical procedure performed to remove the kidney or a part of it. Nephrectomy is of two types, namely, radical nephrectomy in which the entire kidney is removed and partial nephrectomy where a part of the kidney or the diseased tissues is removed as a process of the treatment. Most frequently, a nephrectomy is done to treat kidney cancer or to remove a noncancerous tumor during the urological surgery.
The increase in the prevalence of kidney cancer, kidney diseases and injury to the kidney, rising number of laparoscopic nephrectomy procedures, and growing awareness about organ (kidney) transplant are expected to drive the market growth during the forecast period. However, risks and complications associated with nephrectomy surgery and high cost related to the procedure are anticipated to restrain the market growth.
The Nephrectomy Market market is projected to grow at a CAGR of 4.7% from 2016 to 2025.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansNephrectomy is referred to as the surgical procedure for the removal of the kidney. It is performed as a part of the treatment of the diseased kidney. The nephrectomy based on severity of the disease has been classified into partial and radical nephrectomy procedures. In the partial nephrectomy procedure, the injured or diseased section of the kidney is removed, whereas radical nephrectomy comprises removal of the entire kidney.
Various surgical procedures and technologies are adopted depending on the type of nephrectomy. The procedures comprise laparoscopic surgery, robot-assisted laparoscopic surgery, and others.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2016 – 2018
Forecast Period
2018 – 2025
Primary Interviews
150+
Historical data (2016–2018) and forecast period (2018–2025)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMichael Porter’s five forces model gives a framework that models the global nephrectomy market, which is influenced by five forces. The strategic business managers, trying to create an edge over competing firms in the global nephrectomy market can utilize this model to comprehend better the industry connection in which the firm operates. The components of each of the forces and the degree or impact of each component in the context of the global nephrectomy industry have been broken down and analyzed below.
Bargaining Power of Suppliers
The bargaining power of suppliers in the nephrectomy market is moderate. In this market, the suppliers are medical device manufacturers, laboratory instrument manufacturers, and consumable & accessories manufacturers. There are many major and small companies involved in this market. The bargaining power of suppliers depends on the number of buyers and number of suppliers. In global nephrectomy market the number of buyers is equal to the number of suppliers, and the high cost of switching from one supplier to another increases the bargaining power of suppliers. But, the grey market in medical device industry affects the bargaining power of suppliers. Conclusively the bargaining power of suppliers in the nephrectomy market is m moderate.
Bargaining Power of Buyers
The bargaining power of buyers is moderate to low in the global nephrectomy market. The market has a moderate number of buyers, including clinics, hospitals, surgical centers, and others. The presence of buyers in the market is rising due to the increasing prevalence of kidney cancer, chronic kidney diseases, and other healthcare problem. In addition, the pricing factor also plays an important role in the bargaining power of buyer in the market. The market is characterized by moderate availabilities of substitute products, which holds the buying power at moderate to low.
Threat of New Entrants
The threat of new entrants is moderate to low in the global nephrectomy market. Many medical device manufacturing companies are trying to enter in this market, but the low economies of scale, stringency of government regulations for medical device development and large capital required for the product development hinders the entry of new potential players. But the increasing government support for the healthcare industry supports the new players to enter this market.
Threat of Substitutes
The threat of substitutes in the global nephrectomy market is low. Any threat from a close substitute product is measured to have a high impact on the market. The threat from the substitutes arises when the buyers or the customers in the market can accomplish the end-result using other similar product. Although there is a low number of substitutes or the presence of an alternative line of treatment in the market.
Intensity of Rivalry
The degree of competition in the global nephrectomy market is moderate to high. The moderate degree of product differentiation among existing players increases the intensity of rivalry in the market. Companies involved in the nephrectomy market are trying to develop cost-effective products to make product differentiation more affordable. To overcome the competition, players are engaged in developing a process to lower their manufacturing cost. Moreover, the players are also developing advanced techniques for differentiating their product from their rivals.
Market estimates by geography (2025)
InsightAmericas leads with $2.35B by 2025, while Asia Pacific is projected to grow fastest at a 5.2% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2016 | 2018 | 2025 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $1.26B | $1.58B | $1.90B | 4.7% | 22% |
| Americas | $1.60B | $1.98B | $2.35B | 4.4% | 27% |
| Asia Pacific | $820.50M | $1.06B | $1.30B | 5.2% | 15% |
| Europe | $1.41B | $1.79B | $2.18B | 5.0% | 26% |
| South America | $343.80M | $402.50M | $454.90M | 3.2% | 5% |
| Rest of the World | $244.70M | $310.90M | $376.50M | 4.9% | 4% |
| Total | $5.67B | $7.13B | $8.56B | 4.7% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$8.56B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Laparoscopic Nephrectomy | $5.84B | 4.7% | 85% |
| Robot-Assisted Laparoscopic Nephrectomy | $2.32B | 4.7% | 88% |
| Open Nephrectomy | $393.89M | 4.7% | 54% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Nephrectomy Market covering market dynamics, competitive landscape, and strategic outlook.
The Nephrectomy Market market is projected to reach $8.56B by 2025, growing at 4.7% CAGR. The Laparoscopic Nephrectomy segment holds the largest share.
Nephrectomy is a surgical procedure performed to remove the kidney or a part of it. Nephrectomy is of two types, namely, radical nephrectomy and partial nephrectomy. In a radical nephrectomy, the entire kidney is removed along with some additional structures such as tubes connected to kidney and bladder, lymph nodes, and other parts, whereas in partial nephrectomy (kidney-sparing) only the diseased tissues are removed from the kidney.
Nephrectomy is done to treat kidney diseases, kidney cancer, as well as injuries related to the kidney. The procedure is also done to remove a healthy kidney from a donor for transplantation.
The major key factors driving the market growth are increasing prevalence of kidney cancer, chronic kidney diseases, and injury, rising number of laparoscopic procedures and increasing awareness about organ (kidney) donation cross the globe.
However, factors such as risks and complications of the nephrectomy surgery and high cost related to the procedure hamper the market growth.
Along with various treatment applications, the nephrectomy surgery also leads to cause some risk and complications in the person’s body. The post-operative or surgical complication may depend on patients and their medical conditions. The abdominal pain is common after surgery, but if not cured even after medication, it could cause serious problems to the patient’s health. The postoperative complications after the nephrectomy surgery include infection, bleeding (hemorrhage) requiring blood transfusion, post-operative pneumonia, rare allergic reactions to anesthesia, and sometimes death of the patient. In some cases, the nephrectomy surgery may also cause tissue or organ injury, to surrounding tissues and organs including bowel, spleen, vascular structures, liver, gallbladder, and pancreas which may require further surgery to overcome the problem. Such types of issues and risks associated with the nephrectomy surgery may hinder market growth.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 107 companies operating in the Nephrectomy Market market, including revenue, employee count, and market positioning where available.
Showing 107 of 107 companies
XCELLANCE Medical Technologies
XCELLANCE Medical Technologies (XCELLANCE) is a privately held company that operates in the medical devices industry through its high-end medical equipment. The company offers a variety of products and services. The company has a strong and satisfied customers base owing to the quality and efficiency of its products. It offers products and services to about 3000 hospitals across India.
CONMED Corporation
Company Headquarters: US Founded: 1970 Workforce: 4,500 Company Working: CONMED Corporation is a global medical technology company that provides surgical devices and equipment for minimally invasive procedures. CONMED operates in several segments including Orthopedic Surgery, General Surgery, Gastroenterology, Pulmonology, and Cardiology. One of the products offered by CONMED is the biopsy device, which is used for obtaining tissue samples from the body for diagnostic purposes. Biopsy devices are used in various medical specialties including gastroenterology, urology, pulmonology, and oncology. CONMED offers a range of biopsy devices including disposable and reusable forceps, needles, and brush biopsy instruments. These devices are designed to provide accurate and efficient tissue sampling with minimal patient discomfort. CONMED has a global workforce of above 4,000 employees, with operations in over 20 countries. The company has manufacturing facilities in the United States, Mexico, Costa Rica, France, and the United Kingdom.
Cook Group
Cook Group, a privately held company, operates in the global nephrectomy market through its sub-subsidiary Cook Medical Incorporated (Cook). It is involved in the development of surgical technologies. The company has multiple categories of a wide range of surgical products and services. The company is focused on developing products minimally invasive surgical procedures. The company mainly operates through the vascular and MedSurg divisions. The MedSurg division comprises of surgery, critical care, urology, and others. The company has a strong presence in the Americas, Europe, Asia, and other regions.
Johnson & Johnson Services Inc
Company Headquarters: London, UK Founded: 1971 Workforce: ~ 135,000 Company Working: Johnson & Johnson Services, Inc. (J&J Services) manufactures medical devices for various specialties such as orthopedics, cardiovascular diseases, and many others. J&J Services has acquired and merged with various other companies to expand its portfolio of endoscopic devices. Ethicon, a subsidiary of J&J Services, offers a broad range of suture needle products. Teams from J&J Services’ consumer business are creating digital tools to help people track the health of their skin. Teams working in medical devices are involved in 3D printing of artificial joints personalized for each patient, while researchers in pharmaceuticals use artificial intelligence to discover lifesaving drugs.
Medtronic
Company Headquarters: Dublin, Ireland Founded: 1949 Workforce: ~95,000 Company Working: Medtronic (Medtronic) is a global healthcare solutions company committed to improving the lives of people through medical technologies, services, and solutions. With Covidien, the company has accelerated and advanced its ability to create meaningful innovations for hospitals, health systems, and healthcare providers to deliver the best care possible for patients and their families around the world. The company’s businesses majorly fall into four groups the cardiac and vascular group (CVG), the restorative therapies group (RTG), the diabetes group, and the minimally invasive therapies Group (MITG). The company operates in over 370 locations across almost 160 countries. Medtronic has been awarded more than 4,600 patents.
Olympus Corporation
Company Headquarters: Japan Founded: 1919 Workforce: 46,500 Company Working: Olympus Corporation is a Japanese multinational corporation that specializes in manufacturing and selling optical and reprography products, as well as medical and surgical equipment. The company was founded in 1919 and is headquartered in Tokyo, Japan. Olympus Corporation is organized into four main business segments: Medical, Scientific Solutions, Imaging, and Financial. The Medical segment is the largest and most important business segment of the company, accounting for approximately two-thirds of the company's total revenue. The Medical segment includes endoscopy and surgical products, as well as clinical and research microscopes which includes Biopsy devices. Within the Medical segment, Olympus Corporation offers a range of products for minimally invasive surgical procedures, including endoscopes and endotherapy devices. One of the key products offered by Olympus Corporation is its biopsy device, which is used to collect tissue samples from various parts of the body for diagnostic purposes. Olympus Corporation's biopsy device is designed to be used with endoscopes and comes in a range of sizes and shapes to suit different clinical needs. The company has a global presence with operations in various regions around the world. The company's headquarters is located in Tokyo, Japan, and it has several subsidiaries and offices in different countries.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Nephrectomy Market